MedTrace Logo

Parecoxib for Treatment of Catheter Related Bladder Discomfort

NCT02729935 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-10-18

No results posted yet for this study

Summary

Catheter-related bladder discomfort (CRBD) is defined as an urge to void or discomfort in the supra-pubic region; reported postoperatively in patients who have had urinary catheterization intra-operatively. In the present study, the investigators evaluated Parecoxib (P) for preventing CRBD in patients undergoing catheterization after transurethral resection of bladder tumor (TURBT).

Conditions

  • Postoperative Pain

Interventions

DRUG

Parecoxib

40 mg of intravenous parecoxib 30 min before surgery

DRUG

Placebo

An equal volume of saline

Sponsors & Collaborators

  • University Tunis El Manar

    lead OTHER

Principal Investigators

  • Ali JENDOUBI · University Tunis El Manar

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-05-31
Completion
2016-06-30

Countries

  • Tunisia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02729935 on ClinicalTrials.gov